An immature intestinal epithelial barrier may predispose infants and children to many intestinal inflammatory diseases, such as infectious enteritis, inflammatory bowel disease, and necrotizing enterocolitis. Understanding the factors that regulate gut barrier maturation may yield insight into strategies to prevent these intestinal diseases. The claudin family of tight junction proteins plays an important role in regulating epithelial paracellular permeability. Previous reports demonstrate that rodent intestinal barrier function matures during the first 3 weeks of life. We show that murine paracellular permeability markedly decreases during postnatal maturation, with the most significant change occurring between 2 and 3 weeks. Impaired or immature barrier function plays a key role in the pathogenesis of many intestinal inflammatory diseases of newborns and children, such as idiopathic inflammatory bowel disease (IBD), 1,2 infectious enteritis, or necrotizing enterocolitis (NEC).
Impaired or immature barrier function plays a key role in the pathogenesis of many intestinal inflammatory diseases of newborns and children, such as idiopathic inflammatory bowel disease (IBD), 1,2 infectious enteritis, or necrotizing enterocolitis (NEC). [3] [4] [5] [6] Tight junctions (TJs) maintain separation of tissue compartments by sealing the intercellular space while regulating paracellular permeability. 7, 8 During early postnatal maturation, the intestinal barrier tightens and becomes more selectively permeable in both premature neonates 9, 10 and neonatal animal models. [11] [12] [13] [14] Although dietary and trophic factors, such as epidermal growth factor, 15 and hormonal factors, such as endogenous glucocorticoids, 16 are involved with postnatal intestinal maturation, other factors are likely to play an important role in regulating barrier tightening in the immature gut. Commensal bacteria, which normally colonize the murine gut during the first several weeks of postnatal life, 17 induce expression of genes that improve intestinal barrier function, whereas abnormal bacterial colonization may disrupt this process and contribute to the development of host diseases. 18 Neonates with abnormal intestinal microbial composition may be predisposed to NEC, IBD, or infectious enteritis as the result of a failure in postnatal maturation of this critical protective barrier. The immature neonatal intestinal barrier may fail to prevent systemic entry of microbes or microbial products and other toxins from within the gut lumen, leading to intestinal inflammation and injury. 10,19 -21 Indeed, preterm infants with altered intestinal flora due to prolonged antibiotic therapy are more likely to develop NEC, 22, 23 and abnormal bacterial colonization is implicated in the pathogenesis of IBD. 1 Furthermore, probiotics composed of commensal bacteria have shown promise in reducing the incidence and severity of NEC, 4 IBD, 24 and infectious diarrhea 25 in infants and children. Commensal bacterial signaling through toll-like receptors (TLRs) is vital in maintaining the intestinal barrier. 26 In addition, alterations in TJ protein expression have contributed to impaired barrier function in both IBD 27 and rodent models of NEC. 28, 29 To determine how acquisition of commensal flora in the preterm infant may influence the ontogeny of intestinal barrier function, as regulated by TJ proteins, we modeled preterm human intestinal epithelia using the neonatal mouse. Neonatal murine intestinal epithelia are relatively immature at birth when compared with term human epithelia, and murine intestinal epithelia at 2 weeks postnatally resemble that of a human at 24 gestational age. 30 In addition, the murine gut acquires its complement of flora, beginning at approximately 2 weeks postnatal age. 17 Consistent with previous developmental studies 13, 31 in rodents, we demonstrate that the tightness of the intestinal epithelial barrier, as measured by decreased paracellular permeability, matures over time, with the most significant change occurring at 3 weeks of life.
Claudins, a key component of TJs, demonstrate striking changes in postnatal expression and localization. 32 Here we report for the first time that intestinal barrier function and intestinal expression and localization of claudin 3 may be regulated by signaling from gut flora. Mature expression and localization of claudin 3 occurs at 3 weeks in the postnatal mouse, coincident with maturation in gut permeability. MyD88 null and antibiotic-raised mice both demonstrate impairment in barrier function with deficient expression of claudin 3. Finally, we report that maturation of both gut barrier function and claudin 3 expression can be induced by probiotic administration. Neonatal mice gavage fed Lactobacillus rhamnosus GG (LGG) exhibit increased claudin 3 expression and a dose-dependent acceleration of postnatal barrier maturation. In addition, heat-killed LGG is able to preserve the therapeutic effect of high-dose LGG while reducing associated mortality. These results indicate that intestinal barrier function, as regulated by TJ protein expression, can be influenced by gut flora. Probiotics may act to prevent intestinal diseases in neonates and children by improving intestinal barrier function through induction of appropriate TJ protein expression and localization.
Materials and Methods

Mice
All animal experiments were approved by the Institutional Animal Care and Use Committee at Emory University (Atlanta, GA). C57BL/6J mice were bred in an animal facility at Emory University. MyD88
Ϫ/Ϫ mice, originally generated by Shizuo Akira (Osaka, Japan), were extensively backcrossed onto a C57BL/6 background, as previously described. 33 Tissue samples were harvested at various time points, ranging from embryonic day (E) 18 using timed-pregnant mice to adult (aged 8 weeks). Mice were euthanized by cervical dislocation or decapitation after CO 2 anesthesia. The distal third of the small intestine was immediately frozen for protein assays, placed in RNAlater (Qiagen, Valencia, CA), or frozen in Tissue-Tek Optimal Cutting Temperature medium (Sakura, Torrance, CA) for histological staining.
Antibiotic Treatment
To prevent bacterial colonization of neonatal mice, adult males and females were separated and treated for 3 weeks with neomycin (1 g/L), vancomycin (0.5 g/L), ampicillin (1 g/L), and metronidazole (1g/L) in drinking water to deplete commensal flora, as previously described. 26 Kool-Aid Mix (20 mg/mL) (Kraft Foods, Glenview, IL) was added to drinking water to promote consumption, as previously described. 34 Antibiotic solution was passed through a 0.45 mol/L sterile filter (Millipore, Billerica, MA) and replaced two to three times per week. After 3 weeks, male and female mice were combined for mating and antibiotic water was continued. Cecal images were obtained and compared between antibiotic-treated and control mice as a marker for prevention of bacterial colonization (see Supplemental Figure S1 at http://ajp.amjpathol.org), because cecal enlargement is characteristic of germ-free mice. 35 Enlargement of the cecum is attributed to hydrotropic mucus and retention of water, which is a consequence of the absence of mucolytic bacteria. 30 
LGG Experiments
LGG (American Type Culture Collection, Manassas, VA) was prepared in overnight culture, as previously described, 36, 37 then washed and concentrated in PBS. Mice were gavage fed PBS, with or without LGG [1 ϫ 10 7 to 1 ϫ 10 9 colony-forming units (CFU) per day], in an equal volume daily for 7 days beginning at the age of 1 week. Heat-killed LGG was prepared by exposing the concentrated LGG culture (1 ϫ 10 9 CFU) to 70°C for 30 minutes. Heat-killed samples were examined by plating on MRS media (Becton Dickinson, Franklin Lakes, NJ) under anaerobic conditions and direct visualization by light microscopy to confirm nonviability without disruption of cell wall architecture. To visualize fluorescent LGG within prepared sections of the neonatal distal small intestine by confocal microscopy, the bacterium was stained with the fluorescent amine-reactive dye Cell Trace Far Red DDAO-SE (catalog #C34553, Invitrogen, Carlsbad, CA). Briefly, an overnight culture of LGG, grown in liquid MRS media, was washed twice and resuspended in 1 mL of PBS at a concentration of 1 ϫ 10 9 CFU/mL. The DDAO-SE dye was resuspended in dimethyl sulfoxide, and 12.5 g was added to the washed and resuspended LGG. After oral gavage administration of LGG at a concentration of 1 ϫ 10 9 CFU, the distal small intestine was harvested and frozen in OCT. Frozen tissue sections (8 m thick) were fixed in 4% paraformaldehyde and permeabilized with Triton X-100. Tissue sections were stained with Alexa Fluor 488 phalloidin (A12379; Invitrogen). Immunofluorescent localization was evaluated by confocal microscopy (model LSM510; Zeiss, Oberkochen, Germany).
Claudin Histological Staining
Frozen tissue sections (6 m thick) of distal small intestine were fixed in 100% ethanol at Ϫ20°C for 20 minutes. Sections were stained with primary rabbit anti-claudin 3 (34-1700, Invitrogen) at a 1:500 dilution for 1 hour, followed by secondary anti-rabbit IgG (488 nm) at 1:500 (A11008; Invitrogen) for 1 hour. Nuclei were counterstained with TO-PRO (T3605; Invitrogen) for 2.5 minutes. Immunofluorescent localization was evaluated by confocal microscopy (model LSM510; Zeiss).
Intestinal Permeability Assays
Barrier function was evaluated by measuring in vivo paracellular permeability to fluorescent-labeled dextran, as previously described. 38 Briefly, mice were fasted for 4.5 hours and then gavage fed 22 L/g of 22 g/L fluorescein isothiocyanate-labeled 4.4-kDa dextran (FD4; Sigma, St Louis, MO). Serum was obtained 1 to 5 hours after gavage administration by terminal cardiac puncture (mice aged Ն2 weeks) or decapitation (mice aged 1 week) after CO 2 anesthesia. The serum FD4 concentration was calculated by comparing samples with serial dilutions of known standards using Synergy HT fluorimeter (BioTek, Winooski, VT) with excitation at 485 nm and emission at 530 nm. A gain of 50 was used for all experiments.
Western Blot/Protein Analysis
Intestinal tissue was prepared for Western blot analysis in radioimmunoprecipitation assay lysis buffer, as previously described. 36 Samples were resolved by SDS-polyacrylamide gels and transferred to nitrocellulose by electroblotting. Membranes were probed with primary anti-occludin (71-1500; Invitrogen), anti-claudin 3 (34 -1700; Invitrogen), and anti-claudin 7 (34 -9100; Invitrogen) at 1:500 and secondary goat anti-rabbit IgG (HϩL)-horseradish peroxidase (G21234; Invitrogen) at 1:1000. Equal amounts of protein (20 g) were loaded in each lane, as determined by the Bradford protein assay. Band densitometry analysis was performed using ImageJ software (NIH, Bethesda, MD) and normalized to occludin expression.
Evaluation of mRNA Expression
RNA was extracted using the RNeasy Mini Kit (Qiagen, Valencia, CA) with on-column DNase digestion using the RNAase-Free DNase set (Qiagen), per manufacturer's protocols. All RNA had A260/A280 and A260/A230 ratios between 1.8 and 2.2. Reverse transcription was performed with 0.5 g RNA using the QuantiTect Reverse Transcription Kit (Qiagen). Two-step quantitative realtime PCRs were performed in duplicate for the developmental survey of TJ protein expression and in triplicate for all other assays, with normalization to 18s using the QuantiTect SYBR Green PCR Kit (Qiagen). Gene expression was compared between samples by using the 2 Ϫ⌬⌬CT method. 39 Primers were designed using Beacon Design software (Bio-Rad, Hercules, CA) and OligoAnalyzer (IDT Technologies, Coralville, IA). Full primer sequences are available by request.
Statistical Analysis
Student's t-tests (two groups) or an analysis of variance with a post hoc Tukey's multiple-comparison test (more than two groups) was used where appropriate. In instances in which data demonstrated a nongaussian distribution, a Mann-Whitney U-test (two groups) or a Kruskal-Wallis with Dunn's multiple-comparison test (more than two groups) was used where appropriate. A log-rank Mantel-Cox test was used to compare survival. Prism Version 5 for Windows (GraphPad, La Jolla, CA) was used for all statistical analysis. P Ͻ 0.05 was considered significant. Bars depict mean values, with error bars representing a single measure (SEM).
Results
Murine Intestinal Epithelial Barrier Tightens by 3 Weeks Postnatal Age
Intestinal epithelial barrier function develops postnatally in the neonatal mouse, with the 2-week-old mouse demonstrating similar intestinal epithelial maturity as a 24-week gestational age human. 30 Thus, the neonatal murine gut is often used to model premature human intestines. 36,37,40 -42 To characterize the ontogeny of gut barrier function, we measured in vivo intestinal permeability to 4.4kDa dextran FD4 in the neonatal mouse during the first 8 weeks of life. FD4 is a selective marker for paracellular permeability and has been used to evaluate both intestinal permeability 19 and TJ function. 43 First, to optimize our assay for age-related differences in intestinal transit time, we measured serum FD4 dextran concentrations 1 to 5 hours after oral gavage administration ( Figure 1A ). Serum FD4 dextran peaked at 5 hours after gavage in 2-week-old mice, at 3 to 5 hours in 3-week-old mice, and at 4 hours in adult mice. Thus, all further studies evaluating the development of intestinal epithelial barrier function and paracellular permeability were assayed in mice 5 hours after gavage administration of FD4. Consistent with the idea that the 3-week-old mouse intestine resembles the maturity of a term human intestine, we found significant maturation in gut barrier function (as measured by a fourfold decline in intestinal permeability to FD4 dextran) between 2 and 3 weeks (serum FD4 dextran, 14.9Ϯ3.3 and 3.8Ϯ0.8, respectively; P Ͻ 0.01), with continued decline thereafter ( Figure 1B) . These results indicate that the critical period for maturation of gut barrier function occurs between 2 and 3 weeks of postnatal life in the neonatal mouse and that 2-week-old mice may be used to study the role of immature barrier function in premature intestinal diseases, such as NEC.
Claudin 3 Gene Expression Peaks at 3 Weeks in the Murine Intestine
Alterations in TJ protein expression contribute to impaired barrier function in both IBD 27 and rodent models of NEC. 28 To identify candidate TJ proteins that may play a key role in maturation of intestinal barrier function, we initially quantified intestinal mRNA expression of a panel of TJ proteins during the first 8 weeks of murine life. Several TJ proteins, including claudins 3, 7, and 13, demonstrated 3-to 11-fold increases in mRNA expression from 2 days to 3 weeks of age (Figure 2A ). Based on these findings, we chose to further characterize the developmental mRNA and protein expression of claudins 3 and 7, because they may play a role in tightening of epithelial barriers.
44, 45 We demonstrate that both claudin 3 and 7 mRNA expression peaked at 3 weeks of postnatal age ( Figure 2 , B and C), the same age at which intestinal permeability in the developing postnatal gut significantly decreased ( Figure 1A) . However, the developmental increase in claudin 7 mRNA expression was more variable. These results indicate that claudins 3 and 7 may play a key role in the postnatal maturation of murine intestinal barrier function.
Mature Claudin 3 Protein Expression and Localization Occurs at 3 Weeks in the Murine Gut
To further evaluate the potential relevance of these two candidate TJ proteins to maturation of intestinal barrier function in the 3-week-old mouse, we measured the expression of intestinal claudins 3 and 7 by immunoblot analysis. Protein levels of claudin 3 ( Figure 3 , A and C) demonstrate dramatic increases beginning at 3 weeks postnatal age, whereas expression of occludin, another tetraspan TJ protein, remains relatively constant throughout postnatal development ( Figure 3, A and B ). In contrast, protein levels of claudin 7 ( Figure 3 , B and D) demonstrate no significant developmental changes. Based on the significant increase in claudin 3 expression at 3 weeks postnatal age, we hypothesized that claudin 3 was a potential mediator of postnatal decreases in paracellular permeability seen at 3 weeks of age and selected this candidate TJ protein for further study.
Next, we characterized intestinal claudin 3 localization by immunofluorescent staining and confocal microscopy during the first 8 weeks of murine life ( Figure  3E ). Coincident with increases in both mRNA expression and protein levels, claudin 3 demonstrates mature protein localization at 3 weeks postnatal age, with similar localization as adult mice. Claudin 3 remained localized in the TJs of crypt epithelium in younger mice (2 days and 2 week) and transitioned to additional expression in the mature villous epithelial cells beginning at the age of 3 weeks. These results suggest that appropriate localization and protein levels of claudin 3 may play a key role in maturation of the intestinal barrier in the developing neonatal mouse.
Maturation of Intestinal Claudin 3 Expression and Barrier Function Is MyD88 Dependent
Commensal bacterial signaling through TLRs is vital in maintaining the intestinal barrier. 26 Mice with significantly reduced intestinal commensal bacteria (mice treated with broad-spectrum antibiotics) and mice lacking a key adaptor molecule for TLR signaling (MyD88 Ϫ/Ϫ mice) exhibit exaggerated responses to intestinal injury. 26 Furthermore, studies 46 indicate that TLR signaling, specifically through TLR-2, may play a key role in TJ protein expression and epithelial barrier maturation and protect against TJ disruption in murine colitis. To determine whether acquisition of gut flora, occurring during the first several weeks of murine life, 17 induces expression of claudin 3 through microbial interaction with TLRs, we compared protein expression of claudin 3 in wild-type conventionally reared mice (control) with MyD88 Ϫ/Ϫ and antibiotic-raised wild-type mice at 3 weeks of life. Threeweek-old MyD88 Ϫ/Ϫ and antibiotic-raised wild-type mice exhibit decreased and immature expression of claudin 3, with attenuated immunofluorescent staining in the TJs of surface epithelial cells ( Figure 4A ). In addition, decreased claudin 3 protein levels were observed by using Western blot analysis ( Figure 4B ). The immature expression of claudin 3 appears to be transcriptionally regulated with decreased mRNA expression ( Figure 4C ) noted in MyD88 Ϫ/Ϫ and antibiotic-raised mice at 3 weeks of life compared with control mice. More important, MyD88
and antibiotic-raised mice also demonstrate immature barrier function compared with control mice with significantly increased FD4 intestinal permeability seen in MyD88 Ϫ/Ϫ mice ( Figure 4D ). The trend toward increased permeability in antibiotic-raised mice was associated with increased variability in this group. These results indicate that MyD88-dependent TLR signaling by commensal bacteria may play a key role in the maturation of neonatal murine intestinal barrier function through induction of claudin 3 expression. 
LGG Accelerates Barrier Maturation by Induction of Claudin 3
Delayed or inappropriate intestinal bacterial colonization has been implicated in the pathogenesis of NEC 22, 47 and IBD. 1 Probiotics containing commensal bacterial species, such as Lactobacillus or Bifidobacterium, have reduced the incidence and severity of NEC. 4 Probiotic administration may act by normalizing microbial populations or by directly improving host defense mechanisms. Specifically, probiotics containing commensal bacteria may strengthen intestinal barrier function, which, in turn, may reduce systemic entry of gut luminal microbes or toxins. Our group has previously demonstrated that the probiotic LGG augments host intestinal defense by promoting cytoprotective gene expression. 37 To determine whether LGG can similarly improve epithelial barrier function in the immature murine gut, we compared intestinal claudin 3 expression and barrier function in 2-week-old mice pretreated with enterally administered live LGG, heatkilled LGG, or carrier control. Two-week-old mice gavage fed live or heat-killed LGG at 1 ϫ 10 9 CFU/day (for 1 week) demonstrated significantly improved barrier function with decreased intestinal paracellular permeability when compared with those treated with lower doses or carrier control ( Figure 5A ). In addition, 2-week-old mice treated with high-dose LGG (live or heat killed) exhibited intestinal permeability similar to that of 3-week-old conventionally reared controls, suggesting that early probiotic administration can accelerate developmental barrier maturation. Furthermore, although treatment with live high-dose LGG (1 ϫ 10 9 CFU) was associated with increased mortality, high-dose heat-killed treatment was not ( Figure 5B ). Finally, LGG treatment (1 ϫ 10 9 CFU) resulted in a twofold induction of claudin 3 intestinal mRNA expression ( Figure 6A ) and increased expression of claudin 3 by immunofluorescent microscopy ( Figure  6B ), suggesting that claudin 3 may play a pivotal role in probiotic-induced barrier maturation. In addition, we provide a potential mechanism by which LGG is able to reduce intestinal permeability.
Discussion
Impaired intestinal barrier function has been implicated in the pathogenesis of many intestinal inflammatory syndromes, such as infectious enteritis, IBD, 1,2 and NEC. 3, 4, 48, 49 Thus, investigations aimed at understanding the mechanisms behind the postnatal maturation of intestinal barrier function are critical to developing preventative clinical strategies to reduce the incidence or severity of these devastating diseases. Commensal bacteria up-regulate expression of genes that control intestinal barrier function. 18 In this study, we show that the gene expression of multiple intestinal epithelial TJ proteins is developmentally regulated, with key changes occurring at 2 to 3 weeks of life and coincident with the acquisition of enteric flora in neonatal mice. 17 Developmentally deficient TJ protein expression may contribute to the barrier dysfunction that predisposes to intestinal inflammatory diseases seen in preterm newborns. In this study, the developmental survey of TJ proteins implicated claudin 3 as the most transcriptionally up-regulated TJ protein during an important period of postnatal development. The maturation of claudin 3 protein expression and localization in murine intestinal epithelia occurred simultaneously with maturation of intestinal epithelial barrier function at 3 weeks postnatal age. We were particularly interested in exploring the role of claudin 3 in developmental maturation of barrier function because it is an important tightening claudin that is highly expressed in the mature adult intestine, 50, 51 although its role in the developing intestine remains unclear. Claudin 3 expression is also altered in experimental NEC, 28 and loss of intestinal claudin 3 with urinary detection is associated with intestinal injury in humans and rodents 52 and can be used as a biomarker for early diagnosis and determination of the severity of NEC in premature neonates. 53 Previous reports 28, 29 demonstrate increased intestinal claudin 3 in a rodent model of experimental NEC. However, whether increased intestinal claudin 3 occurs as a response to intestinal injury or predisposes to intestinal injury has not been clear. Our data strongly support the role of claudin 3 as a tightening TJ protein that aids in sealing of the paracellular intestinal barrier, and impaired expression may play a role in predisposition to intestinal disease. Thus, we suspect that increased intestinal claudin 3 expression may be an attempt by the host to repair the epithelial barrier during intestinal injury. The transition of claudin 3 localization from the crypt to villus, occurring at 3 weeks postnatal age, may be critical in establishing a more selective paracellular barrier. Coupled with this transition is increased basolateral expression of claudin 3, although the specific role of basolateral expression of select claudins remains unclear. Potential functions of basolaterally expressed claudins include serving as a pool for functional claudins as TJs undergo assembly and disassembly and involvement in cell signaling. 54, 55 Because MyD88
Ϫ/Ϫ and antibiotic-raised mice demonstrate increased intestinal permeability and reduced claudin 3 expression at 3 weeks of life compared with wild-type mice, commensal bacteria may play a key role in the developmental regulation of intestinal barrier function. Although antibiotic-raised mice demonstrated a trend toward increased permeability, variability in gut barrier function in this group may be the result of hostspecific changes in intestinal flora. Prior studies 56 have demonstrated that altering the normal commensal colonization of rat pups by the administration of antibiotics to pregnant rats alter both postnatal intestinal growth and barrier properties.
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Control
LGG 1x10 7 LGG 1x10 8 LGG 1x10 LGG for 1 week. Intestinal permeability was compared with 3-week-old conventionally raised (CR) mice as a reference point for mature intestinal barrier function. Data are the mean Ϯ SEM from at least three independent experiments. *P Ͻ 0.05, **P Ͻ 0.01. B: Kaplan-Meier survival curve for the same experimental groups as described in A. The percentage survival and the number of mice per group are indicated. ***P Ͻ 0.001 by log-rank Mantel-Cox test.
LGG We suspect that TLR interaction with bacterial ligands may play a significant role in claudin 3-dependent barrier maturation. However, the signaling pathways linking TLR activation and claudin 3 expression in the developing intestine remain poorly understood and are an area for future study. Interestingly, maturation of intestinal permeability (3 weeks) seems to occur approximately 1 week after acquisition of commensal flora (2 weeks) in the mouse. Similarly, increased barrier function in response to the probiotic LGG occurred after 1 week of treatment in our studies. These data suggest that the use of probiotics clinically to modulate intestinal barrier function may be most effective in preventing, rather than treating, disease.
Probiotics remain a promising therapy in intestinal diseases, particularly those that affect the immature epithelia of preterm human intestines. Given that an immature intestinal barrier likely plays a role in the pathogenesis of NEC, 57, 58 probiotics may restore or replace essential strains of commensal flora necessary for barrier maturation in a preterm gut that is impaired by delayed commensal colonization and low bacterial diversity. 59 Lactobacillus species specifically appear to be a critically sensitive commensal that is lacking in preterm infants and is also more susceptible to eradication in response to antibiotic treatment and stress. 59 Lactobacillus species have reduced Rotaviral-induced increases in intestinal permeability in immature suckling rats, 60 and previous groups have demonstrated the therapeutic potential of both live 36 and heat-killed LGG on reducing inflammation in immature epithelia. 61 In our study, up-regulation of claudin 3 expression by LGG treatment was associated with acceleration in the developmental maturation of the intestinal barrier. Whether probiotic-induced up-regulation of claudin 3 expression and barrier maturation can reduce or prevent infectious enteritis, NEC, or IBD experimentally remains an area of future investigation. Although results from both human trials and experimental animal models have generated encouraging data regarding the beneficial effects of probiotics in reducing NEC incidence and severity, the widespread use of probiotic therapy is limited by concerns regarding adverse effects, such as sepsis. 62, 63 These concerns parallel our findings in which mice treated with high-dose LGG demonstrate significantly increased mortality. The risks of administration of live bacteria to an intestine with an immature epithelial barrier are particularly relevant in our study. We demonstrated increased mortality when 1-week-old mice were treated with live high-dose LGG (1 ϫ 10 9 CFU/day for 7 days). Our data indicate that mice Ͻ3 weeks old have a leaky intestinal paracellular barrier. This immature neonatal intestinal epithelial barrier may be permeable to bacteria or bacterial products, which, in turn, may cause increased morbidity and mortality if bacteria penetrate the epithelial barrier. Supporting this idea, we gavage fed 2-week-old mice with fluorescently labeled LGG, and demonstrated multiple bacteria crossing the intestinal epithelial barrier into the lamina propria (see Supplemental Figure S2 at http://ajp.amjpathol.org). Similar concerns regarding appropriate dosing of probiotic strains are highlighted in a recent study, 64 in which preterm piglets treated with high doses of live probiotic strains developed a higher incidence of NEC. Promisingly, we recapitulated the positive effect of live high-dose LGG with heat-killed LGG while avoiding the associated mortality. This supports the therapeutic use of either purified or nonviable bacterial products that may replicate the beneficial effects of live probiotics without the associated risks.
In conclusion, these data provide evidence that commensal and probiotic bacteria play a key role in the developmental maturation of the intestinal barrier by regulating claudin 3 protein expression. More important, our data indicate that probiotic administration can accelerate the maturation of both claudin 3 protein expression and intestinal barrier function in an immature gut lacking commensal bacteria. Thus, one mechanism by which probiotics may prevent intestinal diseases affecting neonates and children is by inducing maturation of claudin 3 protein-regulated intestinal epithelial permeability. Furthermore, our study highlights the importance of exercising caution when considering the therapeutic use of live probiotics in hosts with immature or compromised barrier function. Heat-killed probiotics may be a promising alternative to live bacteria as a therapy with significantly less risk for adverse outcomes. Future studies aimed at investigating the signaling pathways stimulated by probiotic bacteria that can regulate intestinal TJ protein expression and barrier function may aid in the development of targeted therapies to prevent or reduce the severity of infant and childhood intestinal inflammatory syndromes.
